Blockbuster Drugs
The Rise and Fall of the Pharmaceutical Industry
- Publisher's listprice GBP 45.49
-
20 538 Ft (19 560 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 2 054 Ft off)
- Discounted price 18 484 Ft (17 604 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
20 538 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP USA
- Date of Publication 23 January 2014
- ISBN 9780199737680
- Binding Hardback
- No. of pages238 pages
- Size 211x145x20 mm
- Weight 431 g
- Language English
- Illustrations 22 black and white halftones 0
Categories
Short description:
Examines the cases of several historic and high-profile drugs in order to discuss the future of the pharmaceutical industry.
MoreLong description:
Blockbuster drugs-each of which generates more than a billion dollars a year in revenue-have revolutionized the industry since the early 1980s, when sales of Tagamet alone transformed a minor Philadelphia-based firm into the world's ninth-largest pharmaceutical company. In Blockbuster Drugs, Jie Jack Li tells the fascinating stories behind the discovery and development of these highly lucrative medicines, while also exploring the tumult the industry now faces as the "patent cliff" nears.
Having spent most of his career in drug research and development, Li brings an insider's eye to the narrative as he recounts the tales of discovery behind such drugs as Tagamet, Zantac, Claritin, Prilosec, Nexium, Serouquel, Plavix, and Ambien. As he discusses each breakthrough, Li also shows that scientific research is filled with human drama-serendipitous discoveries, sudden insights, tense confrontations. For instance, the author tells of James Black, who persisted in the research that led to Tagamet-and that would ultimately win him a Nobel Prize-despite pressure from top executives to pursue "more profitable" work. The book shows how research behind Prilosec combined creativity, international cooperation, and luck-the turning point being a chance encounter of American and Swedish scientists at a conference in Uppsala. There are also tales of fabulous rewards--George Rieveschl, the chemist who invented Benadryl, made a fortune on royalties-and of unjust desserts. Finally, Li shows that for the world's largest prescription drug manufacturers, recent years have been harrowing, as many popular drugs have come off patent in the U.S. market, meaning hundreds of billions of dollars in lost revenue.
Anyone who enjoys tales of scientific discovery, or is curious about the history behind the prescriptions they take, or wants a revealing inside look at the pharmaceutical industry will find this book well worth reading.
Table of Contents:
Table of Contents
Chapter 1 Before the Age of Blockbuster Drugs
Chapter 2 The Beginning of an Era - The First Blockbuster Drug Tagamet
Chapter 3 More Blockbuster Drugs for Ulcer
Chapter 4 Antihistamines as Allergy Medicines
Chapter 5 Blood Thinners, From Heparin to Plavix
Chapter 6 Conquest of Pain--Analgesics: from Morphine to Lyrica
Chapter 7 Lessons
Bibliography
Appendix
Index
